Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03179878 · ClinicalTrials.gov registry record · Phase 1
Safety and Tolerability of SYNB1020-CP-001
A Phase 1 study, sponsored by Synlogic.
- Completed
- Registry status
- Phase 1
- Development phase
- 52
- Enrollment target
NCT03179878 is a Phase 1 study that has completed, run by Synlogic. The registered enrollment target is 52 participants.
The verdict
NCT03179878, a Phase 1 study, has completed, sponsored by Synlogic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 52 participants
- Enrollment target
Study Summary
A Phase 1, First-in-human, Oral Single and Multiple Dose-Escalation, Randomized, Double-blinded, Placebo-controlled Study of SYNB1020 in Healthy Adult Volunteers to Evaluate Safety, Tolerability, Dosing, and Pharmacodynamics
Interventions
- DRUG Placebo
- DRUG SYNB1020
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2017-06-16 |
| Est. Completion | 2018-04-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03179878
The ClinicalTrials.gov registry entry for NCT03179878 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Synlogic, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03179878 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03179878 about?
NCT03179878 is a clinical study titled "Safety and Tolerability of SYNB1020-CP-001". A Phase 1, First-in-human, Oral Single and Multiple Dose-Escalation, Randomized, Double-blinded, Placebo-controlled Study of SYNB1020 in Healthy Adult Volunteers to Evaluate Safety, Tolerability, Dosing, and Pharmacodynamics
What is the current status of trial NCT03179878?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 52 participants. The study started on 2017-06-16. Estimated completion is 2018-04-11.
What interventions are being tested in trial NCT03179878?
The interventions under investigation include: Placebo (DRUG), SYNB1020 (DRUG).
Who is sponsoring clinical trial NCT03179878?
This trial is sponsored by Synlogic, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.